Use of 99mTc Tilmanocept for Imaging Arterial Inflammation

Trial Profile

Use of 99mTc Tilmanocept for Imaging Arterial Inflammation

Phase of Trial: Phase IV

Latest Information Update: 29 Jan 2018

At a glance

  • Drugs Tc 99m tilmanocept (Primary)
  • Indications Cardiovascular disorders
  • Focus Diagnostic use; First in man
  • Most Recent Events

    • 18 Jan 2018 Planned number of patients changed from 24 to 31.
    • 09 Oct 2017 New trial record
    • 15 Apr 2017 Status changed from recruiting to completed as per the results published in the Journal of Infectious Diseases.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top